Table 4.
Evaluation profile: dates, sampling, and intervention grouping, by country
| Malawi | Rwanda | Ethiopia | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Evaluation dates: | ||||||||||
| Baseline (BL) |
May – June 2010 |
Sept – Nov 2010 |
July – Sept 2010 |
|||||||
| Follow up* (FU) |
Jan – Mar 2013 |
Apr – May 2013 |
Oct – Dec 2012 |
|||||||
| Intervention kickoff and duration of testing period |
EM and EPT training (June – Dec 2011)
Monitoring and Intervention support (Jan 2012 – Feb 2013) |
RSPs (Aug 2011 – March 2013)
QCs (April 2012 – March 2013)
IcSCI (April 2012 – March 2013) |
Ready Lessons/Problem Solving
TOTs for HCs (Oct – Dec 2011)
Assumed rollout to HEWs (Jan – June 2012) |
|||||||
|
Overall LIAT sample: | ||||||||||
| Districts FU (BL) |
10 (10) of 28 nationwide† |
10 (10) of 31 nationwide‡ |
28 (26) Woredas of ~ 765 woredas nationwide§
12 (9) Zones of ~ 85 nationwide§ |
|||||||
| Health Centers FU (BL) |
76 (77) |
108 (100) |
82 (74) |
|||||||
| CHWs FU (BL) |
249 (249) |
349 (321) |
263 (245) Health Posts |
|||||||
|
LIAT sample size by intervention group: | ||||||||||
|
EM |
EPT |
Comparison |
QCs |
IcSCI |
Comparison |
Intensive |
Non–intensive |
Comparison OJT |
||
| District/Woreda FU (BL) |
3 (3) |
3 (3) |
4 (4) |
3 (3) |
3 (3) |
4 (4) |
8 (8) |
10 (9) |
10 (9) |
|
| Health Centers FU (BL) |
25 (26) |
23 (25) |
28 (26) |
31 (30) |
37 (31) |
40 (39) |
24 (28) |
30 (20) |
28 (26) |
|
| CHWs FU (BL) |
81 (81) |
78 (83) |
90 (85) |
105 (85)
70 (0) CCs |
116 (102)
78 (0) CCs |
128 (134) |
80 HPs (69) |
92 (102) |
91 (74) |
|
|
% CHWs managing iCCM products: | ||||||||||
| BL |
139 of 249 (56%) manage any health products (including iCCM, FP, HIV) |
65%of 321 manage amoxicillin 250mg, ORS, zinc 20mg, Primo Rouge (ACT 1 × 6), Primo Jaune (ACT 2 × 6) |
71 of 245 (29%) manage ORS, RUTF any ACT, COCs, and DMPA |
|||||||
| FU | 100% of 249 manage cotrimoxazole 480mg, both LA (1 × 6 and 2 × 6), and ORS | 94% of 349 manage amoxicillin, 150mg, ORS, zinc 10mg, Primo Rouge (ACT 1 × 6), Primo Jaune (ACT 2 × 6) | 151 of 263 (58%) manage ORS, RUTF, any ACT, COCs, and DMPA | |||||||
ACT – artemisin–based combination therapy, BL– baseline, COC – combined oral contraceptives, CHW – community health worker, DMPA – depo provera/depot medroxyprogesterone acetate EM – enhanced management, EPT – efficient product transport, FP – family planning, FU – follow up, HEW – Health Extension Worker, HC – health center, HIV – human immunodeficiency virus, iCCM – integrated community case management, IcSCI – Incentives for Community Supply Chain Improvement, LA – artemether/lumefantrine, LIAT – logistics indicator assessment tool, OJT – on the job training, ORS – oral rehydration solution, QC – Quality Collaboratives, TOT – training of trainer, RUTF – ready-to-use therapeutic food
*Follow up survey results also referred to as Follow Up survey in Tables 5, 6 and 8 and text.
†Source: CIA World Factbook (https://www.cia.gov/library/publications/the-world-factbook/geos/mi.html). Accessed: 10 November, 2014.
‡Source: National Institute of Statistics, Rwanda; 2006. Available: http://www.statistics.gov.rw/geodata. Accessed: 10 November 2014.
§Source: Population and Housing Census Report – Country – 2007. Central Statistical Agency, 2010–2007. Available at: (http://www.csa.gov.et/newcsaweb/images/documents/surveys/Population%20and%20Housing%20census/ETH-pop-2007/survey0/data/Doc/Reports/National_Statistical.pdf. Accessed: 10 November, 2014.